What happens when a rare cancer keeps coming back, defying every treatment thrown at it? For adults battling relapsed marginal zone lymphoma (MZL), a subtype of non-Hodgkin lymphoma, this relentless cycle has long been a harsh reality, but a flicker of hope emerges as Bristol Myers Squibb’s
Imagine a cellular mechanism so fundamental to life that it not only kickstarts DNA replication but also holds the reins of gene expression, dictating which genetic instructions are read or silenced in human cells. The origin-recognition complex (ORC), long understood as the spark for DNA copying,
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development has positioned him at the forefront of innovation in cancer treatment. With a deep understanding of cutting-edge technologies, Ivan has been exploring groundbreaking
In a groundbreaking development for medical science in Southern California, the University of California San Diego (UC San Diego) has been awarded an $80 million, seven-year grant from the National Center for Advancing Translational Sciences (NCATS), a division of the National Institutes of Health
In an era where the pharmaceutical industry faces unprecedented challenges in bringing new drugs to market, a recently released industry analysis has spotlighted the trailblazers driving innovation in drug discovery services. Published on August 14, this comprehensive evaluation dives deep into the
Imagine a rural clinic in a low-resource region, where a patient arrives with symptoms of a deadly infectious disease, yet the nearest diagnostic lab is hundreds of miles away, and results could take days or even weeks. This scenario plays out daily across the globe, contributing to the staggering
